Ein neuer Test zur Risikoberechnung für chromosomale Trisomien im ersten Schwangerschaftsdrittel[1]

Literatur

• 1 Braulke I, Rauskolb R. Blutuntersuchungen bei Schwangeren zur pränatalen Risikopräzisierung für Chromosomenanomalien und Neuralrohrdefekte.  Med Genetik. 1996;  4 348-352
• 2 Chitayat D, Kalousek D K, Bamforth J S. Lymphatic abnormalities in fetuses with posterior cervical cystic hygroma.  Am J Med Gen. 1989;  33 52-56
• 3 Eiben B, Sancken U. Computer software programs and Down`s syndrome risk calculations.  Lancet. 1996;  347 1553-1554
• 4 Eiben B, Hammans W, Hansen S. et al . On the complication risk of early amniocentesis versus standard amniocentesis.  Fet Diagn Ther. 1997;  12 140-144
• 5 Eiben B, Hammans W, Goebel R, Epplen J T. Die Fluoreszenz in situ Hybridisierung (FISH) an unkultivierten Amnionzellen: Ein neuer Schnelltest für einige definierte Chromosomenstörungen?.  Dt Ärztebl. 1998;  95A 1304-1306
• 6 Eiben B, Trawicki W, Hammans W, Goebel R, Pruggmayer M, Epplen J T. Rapid prenatal diagnosis of aneuploidies in uncultured amniocytes by fluorescence in situ hybridisation (FISH) - An evaluation of over 3000 cases.  Fet Diagn Ther. 1999;  14 193-197
• 7 Germer U, Gembruch U, Geipel A, Krapp M, Diedrich K. Frühes Fehlbildungsscreening als Entscheidungsgrundlage für oder gegen eine Karyotypisierung in der Schwangerschaft.  Frauenarzt. 1998;  39 242-255
• 8 Haddow J E, Palomaki G E, Knight G J, Williams J, Miller W A, Johnson A. Screening of maternal serum for fetal Down`s syndrome in the first trimester.  N Engl J Med. 1998;  338 955-961
• 9 Huisman T W, Bilardo C M. Transient increase in nuchal translucency thickness and reversed end-diastolic ductus venosus flow in a fetus with trisomy 18.  Ultrasound Obstet Gynecol. 1997;  10 397-399
• 10 Hyett J A, Brizot M L, von Kaisenberg C S, McKie A T, Farzaneh F, Nicolaides K H. Cardiac gene expression of atrial natriuretic peptide and brain natriuretic peptide in trisomic fetuses.  Obstet. Gynecol.1996;  87 506-510
• 11 Hyett J A, Moscoso G, Nicolaides K H. Abnormalites of the heart and great arteries in first trimester chromosomally abnormal fetuses.  Am J Med Genet.. 1997;  69 207-216
• 12 Hyett J A, Perdu M, Sharland G K, Snijders R J, Nicolaides K H. Increased nuchal translucency at 10-14 weeks of gestation as a marker for major cardiac defects.  Ultrasound Obstet Gynecol. 1997;  10 242-246
• 13 Kurnit D M, Layton W M, Matthyse S. Genetics, chance and morphogenesis. in: Epstein CJ, ed. Morphogenesis of Down syndrome Wiley Liss, New York 1987: 19-41
• 14 Matias A, Gomes C, Flack N, Montenegro N, Nicolaides K . Screening for chromosomal abnormalities at 11-14 weeks: the role of ductus venosus blood flow.  Ultrasound Obstet Gynecol. 1998;  12 380-384
• 15 Miny P, Holzgreve W. Indikationen, Möglichkeiten und Grenzen der Zytogenetik in der pränatalen Diagnostik.  Med Genet. 1999;  11 359-364
• 16 Montenegro N, Matias A, Areias J C, Castedo S, Barros H. Increased fetal nuchal translucency: possible involvement of early cardiac failure.  Ultrasound Obstet Gynecol. 1997;  10 265-268
• 17 Morris J K, Wald N J, Watt H C. Fetal loss in Down syndrome pregnancies.  Prenat Diagn. 1999;  19 142-145
• 18 Nicolaides K, Sebire N, Snijders J M. The 11-14 week scan - The diagnosis of fetal anomalies. Parthenon Publishing, New York, London 1999
• 19 Pauer H U, Rauskolb R. Blutuntersuchungen bei Schwangeren zur pränatalen Erkennung von Chromosomenanomalien und Neuralrohrdefekten.  Frauenarzt. 1999;  40 518-522
• 20 Sancken U, Bahner D. The effect of thermal instability of intact human chorionic gonadotropin on the application of it`s free ß subunit as a serum marker in Down syndrome sreening.  Prenat Diag. 1995;  15 731-738
• 21 Schmidtke J. Die Indikationen zur Pränataldiagnostik müssen neu begründet werden.  Med Genet. 1995;  7 49-52
• 22 Schuchter K, Wald N, Hackshaw A K, Hafner E, Liebhart E. The distribution of nuchal translucency at 10-13 weeks of pregnancy.  Prenat Diagn. 1998;  18 281-286
• 23 Sebire N J, Snijders R J, Davenport M, Greenough A, Nicolaides K H. Fetal nuchal translucency thickness at 10-14 weeks" gestation and congenital diaphragmatic hernia.  Obstet Gynecol. 1997;  90 943-46
• 24 Shepard T H, Fantel A G. Pathogenesis of congenital defects associated with Turner"s syndrome: The role of hypoalbuminemia and edema.  Acta Endocrinol Suppl (Copenh). 1986;  279 440-47
• 25 Snijders R JM, Nicolaides K H. Assessment of risk. In: Ultrasound Markers for Fetal Chromosomal Defects. Carnforth. Parthenon Publishing New York, London, 1996: 109-113
• 26 Snijders R JM, Noble P, Souka A, Nicolaides K H. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation.  Lancet. 1998;  351 343-346
• 27 Souka A P, Snijders R J, Novakov A, Soares W, Nicolaides K H. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation.  Ultrasound Obstet Gynecol. 1998;  11 391-400
• 28 Spencer K, Souter V, Tul N, Snijders R, Nicolaides K H. A rapid screening program for trisomy 21 at 10-14 weeks using fetal nuchal tranclucency, maternal serum free β-hCG and PAPP-A.  Ultrasound Obstet Gynecol. 1999;  13 231-237
• 29 Szabo J, Gellen J. Nuchal fluid accumulation in trisomy-21 detected by vaginosonography in first trimester.  Lancet. 1990;  336 1133
• 30 Tul N, Spencer K, Noble P, Chan C, Nicolaides K. Screening for trisomy 18 by nuchal translucency and maternal serum free β-hCG and PAPP-A at 10-14 weeks of gestation.  Prenat Diagn. 1999;  19 1035-1042
• 31 von Kaisenberg C S, Huggon I, Hyett J A, Farzaneh F, Nicolaides K H. Cardiac expression of sarcoplasmic reticulum calcium ATPase in fetuses with trisomy 21 and trisomy 18 presenting with nuchal translucency.  Fetal Diagn Ther. 1997;  12 270-73
• 32 von Kaisenberg C S, Brand-Saberi B, Christ B, Vallian S, Farzaneh F, Nicolaides K H. Collagen type VI gene expression in the skin of trisomy 21 fetuses.  Obstet Gynecol.. 1998;  91 319-323
• 33 von Kaisenberg C S, Krenn V, Ludwig M, Nicolaides K H, Brand-Saberi B. Morphological classification of nuchal skin in fetuses with trisomy 21, 18 and 13 at 12-18 weeks and in a trisomy 16 mouse.  Anat Embryol. 1998;  197 105-124
• 34 von Kaisenberg C S, Nicolaides K H, Brand-Saberi B. Lymphatic vessel hypoplasia in fetuses with Turner syndrome.  Hum Reprod. 1999;  14 823-826
• 35 von Kaisenberg C S, Brand-Saberi B, Jonat W, Nicolaides K H. Pathophysiology of increased nuchal translucency in chromosomally abnormal fetuses.  Pren Neonat Med. 1999;  4 1-10
• 36 Wald N J, Kennard A, Hackshaw A K. First Trimester serum screening for Down`s Syndrome.  Prenat Diag. 1995;  15 1227-1240
• 37 Wald N J, Watt H C, Hackshaw A K. Integrated screening for Down`s syndrome based on tests performed during the first and second trimesters.  N Engl J Med. 1999;  341 461-463
• 38 Wissenschaftlicher Beirat der Bundesärztekammer . Richtlinien zur pränatalen Diagnostik von Krankheiten und Krankheitsdispositionen.  Dt Ärztebl. 1998;  95 3236-3242

1 Die Verfasser widmen diese Arbeit Herrn Prof. Dr. med. H. H. Stange zu seinem 80. Geburtstag.

Korrespondenz